Arbios sells bioartificial liver system to HepaLife Technologies
The terms of the deal included $450,000 in cash and a five-year warrant to purchase 750,000 shares of HepaLife’s common stock. Arbios has received $250,000 at the closing

The terms of the deal included $450,000 in cash and a five-year warrant to purchase 750,000 shares of HepaLife’s common stock. Arbios has received $250,000 at the closing

HairDX said that it will soon begin recruiting post menopausal women as patients for the study. Women who qualify for the study will undergo genetic screening. If they

The company said that the 30,000sqft facility almost doubles its membrane production capabilities in Ireland. The new $83 million dollar membrane casting facility is expected to produce a

The single award contract has a five-year base period of performance for an estimated value of $4.1 million if all options are exercised. Under the new contract, Bridge

OsoLean whey protein supplement is an all-natural powder product that mixes with a variety of food and beverages so consumers can easily add it to any weight and

According to Great Basin Scientific, the new round of financing will fund the company through the spring of 2009 as it completes the design of its rapid molecular

The company will occupy approximately 20,000sqft of office space located north of the San Francisco International Airport at 2000 Sierra Point Parkway, adjacent to Highway 101. The facility

The brain cancer test is a molecular diagnostic test developed and validated at The University of Texas MD Anderson Cancer Center to prospectively demonstrate responsiveness to treatment for

The company has previously announced a letter of intent to enter into a contractual arrangement with Qinba. Under the terms of this arrangement, Huifeng will assume operational control

According to the company, the versatile instrumentation and flexibility of the Apex system allows surgeons to match the surgical approach to the specific pathology of the patient. In